NR3C2 and hypertensive retinopathy: Early use of MR antagonists such as spironolactone, at doses of 2-12.5mg/kg/day, can normalize blood pressure, improve growth, reverse hypertensive retinopathy and left ventricular hypertrophy, and there is literature indicating that it can also reverse bilateral nephrocalcinosis (4, 16).